June 6, 2024
mayank
WhiteOak Capital Pharma and Healthcare Fund details, NAV, Portfolio, Returns, Peer Comparison, Fund Managers & Guidance by Chanakyamfguidance.com
NAV Growth: Rs 10.2630
Suitable For Which Investors?
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route.
Fund’s Investment Strategy:
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund Manager:
1) Ramesh Mantri
Education: Mr. Mantri is an MBA, CFA and CA
Experience: Prior to joining WhiteOak Capital Mutual Fund, he has worked with WhiteOak Capital Management, Ashoka Capital Advisers, Smith Management, and CRISIL.
2) Piyush Baranwal
Education: Mr.Piyush Baranwal is a B. Tech. in Electronics and communication from Manipal Institute of Technology,Manipal.He completed PGDBM in Finance from S.P.Jain Institute of Management and Reserch and CFA.
Experience: Prior to joining WhiteOak Capital Mutual Fund he has worked with BOI AXA, Morgan Stanley Investment Management (Jan, 2011-June, 2014) and Principal Pnb AMC as a Dealer- Fixed Income (May, 2008-Jan, 2011).
3) Dheeresh Pathak
Education: Mr. Pathak has done B.E in Electronics Engineering and a PGDBM from MDI Gurgaon
Experience: Prior to joining WhiteOak Capital Mutual Fund, he has worked with Goldman Sachs
Investment Details
| Min. Investment (Rs) | 100 |
| Min. Addl Investment (Rs) | 100 |
| Min. SIP Investment (Rs) | 100 |
| Min. Withdrawal (Rs) | 500 |
| Min. No of Cheques | 6 |
| Min. Balance (Rs) | — |
| Lock-in Period | NA |
| Exit Load | 1% for redemption within 1 month |
Basic Details
| Fund House | WhiteOak Capital Mutual Fund |
| Launch Date | 06-Feb-24 |
| Return Since Launch | 2.63% |
| Benchmark | BSE Healthcare TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | Rs 113 Cr |
| (As on 30-Apr-2024) | |
| Expense | 0.61% |
| (As on 30-Apr-2024) | |
| Risk Grade | — |
| Return Grade | — |
| Turnover | — |
Trailing Returns (%) of WhiteOak Capital Pharma and Healthcare Fund
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| WhiteOak Capital Pharma and Helthcr Dir | — | 3.88 | 0.08 | 2.97 | — | — | — | — | — | — |
| BSE Healthcare TRI | — | 3.45 | 0.04 | 2.54 | — | — | — | — | — | — |
| Equity: Sectoral-Pharma | — | 3.33 | 0.34 | 2.41 | — | — | — | — | — | — |
| Rank within category | — | 1 | 11 | 8 | — | — | — | — | — | — |
| Number of funds in category | 15 | 17 | 17 | 16 | 14 | 12 | 10 | 8 | 4 | 3 |
Peer Comparison of WhiteOak Capital Pharma and Healthcare Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| WhiteOak Capital Pharma and Helthcr Dir | Unrated | — | — | — | 0.61 | 113 | 2.63 | 1.00 (30) | 4M | — |
| ICICI Pru Pharma Healthcare and Diagnostics Dir | 4 star | 54.51 | 16.74 | 27.19 | 1.03 | 3,835 | 22.58 | 1.00 (15) | 5Y 10M | 86.00 |
| SBI Healthcare Opportunities Dir | 5 star | 47.20 | 16.40 | 26.64 | 0.95 | 2,667 | 17.80 | 0.50 (15) | 11Y 5M | 38.00 |
| Tata India Pharma & Healthcare Dir | 4 star | 49.98 | 16.76 | 25.66 | 0.83 | 894 | 13.48 | 0.25 (30) | 8Y 5M | 27.14 |
| Nippon India Pharma Dir | 3 star | 50.28 | 15.37 | 26.18 | 0.92 | 7,133 | 18.48 | 1.00 (30) | 11Y 5M | 14.00 |
Portfolio Analysis of WhiteOak Capital Pharma and Healthcare Fund
| No. of Stocks | 33 |
| Top 10 Stocks | 52.74% |
| Top 5 Stocks | 35.75% |
| Top 3 Sectors | 99.98% |
| Portfolio P/B Ratio | 5.74 |
| Portfolio P/E Ratio | 43.76 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 40,867 | 71,992 |
| Giant (%) | 11.77 | 18.50 |
| Large (%) | 34.42 | 42.70 |
| Mid (%) | 35.29 | 28.48 |
| Small (%) | 18.52 | 11.54 |
| Tiny (%) | — | 0.94 |
How to Invest in WhiteOak Capital Pharma and Healthcare Fund?
Chanakya’s Mutual Fund Guidance For WhiteOak Capital Pharma and Healthcare Fund
Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Apply Online: https://mf.whiteoakamc.com/our-funds
>> Post your MF questions @ sahifund.com/ask-me/
>> NFO Guidance:
https://sahifund.com/category/nfos/
>> Chanakya’s Mutual Fund Guidance on YouTube
https://www.youtube.com/c/ChanakyaNiPothi
>> Join Chanakya MF’s Telegram Channel @
https://t.me/chanakyaMFGuidance
Quicklinks